TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial.

Charlotte Duch Lynggaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.